PROGESTERON FOR TREATMENT AND PREVENTION OF SPONTANEOUS PRETERM BIRTH Russian patent published in 2014 - IPC A61K31/57 A61P15/06 

FIELD: medicine.

SUBSTANCE: group of inventions relates to medicine, namely to obstetrics and gynaecology, and can be used for minimisation of cervix shortening in a pregnant woman with the shortened cervix approximately from more than 1.5 cm to 3.5 cm. For this purpose a medication, including progesterone, selected from natural progesterone, progesterone metabolite, 17-alpha-hydroxy-progesteron, medroxyprogesterone acetate, norethindrone, norehtindrone acetate, norethindrone enanthate, desogestrel, levonorgestrel, lynestrenol, ethynodiol diacetate, drospirenone, trimegestone, levodesogestrel, gestodene, nesterone, etogestrel and 19-nortestosterone derivatives, which is in the form of a vaginal gel, vaginal cream or in the form of a solid vaginal drug is introduced to the said woman. The medication is also claimed.

EFFECT: group of inventions provides treatment or prevention of spontaneous preterm birth in pregnant women, complications and mortality among newborn children.

23 cl, 14 dwg, 2 tbl, 2 ex